Popular Posts
-
Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announce... -
Telormedix, a clinical stage biopharmaceutical company focused on targeted immunity in the treatment of cancer and other diseases, today ann... -
A preliminary study has found that a targeted treatment for medulloblastoma -- the most common malignant brain cancer in children -- may o...
-
The liver scarring of alpha1-antitrypsin (AT) deficiency, the most common genetic cause for which children undergo liver transplantation, mi...
-
The U.S. Food and Drug Administration today announced plans to hold a public meeting on July 19-20, 2010, to discuss how the agency will ov... -
After years of research and anticipation, insulin pills that could make it easier for millions of patients worldwide to manage diabetes are...
-
CorMedix Inc. ("CorMedix") , a pharmaceutical company focused on developing and commercializing therapeutic products for the p... -
Bristol-Myers Squibb Company (BMS) and Pfizer announced that the companies have agreed to stop the phase 3 AVERROES clinical trial of apix... -
AGA Medical today announced first patient enrollment in the feasibility phase of the prospective, multicenter, randomized AMPLATZER(R) Card... -
NeuroDerm, Ltd. announced the successful enrollment and dosing in its Phase I clinical trial of ND0611. ND0611, a proprietary drug formula ...
